These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 31461715

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
    Vita R, Settineri S, Liotta M, Benvenga S, Trimarchi F.
    Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol.
    Arnold JD, Sarkodie EP, Coleman ME, Goldstein DA.
    J Sex Med; 2016 Nov; 13(11):1773-1777. PubMed ID: 27671969
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P, Stevenson MO, Suppakitjanusant P, Goodman M, Tangpricha V.
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [Abstract] [Full Text] [Related]

  • 11. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
    Defreyne J, Elaut E, Kreukels B, Fisher AD, Castellini G, Staphorsius A, Den Heijer M, Heylens G, T'Sjoen G.
    J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926
    [Abstract] [Full Text] [Related]

  • 12. Self-perception of voice in transgender persons during cross-sex hormone therapy.
    Bultynck C, Pas C, Defreyne J, Cosyns M, den Heijer M, T'Sjoen G.
    Laryngoscope; 2017 Dec; 127(12):2796-2804. PubMed ID: 28730692
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association between serum estradiol and cardiovascular health among transgender adults using gender-affirming estrogen therapy.
    Rytz CL, Miranda KT, Ronksley PE, Saad N, Raj SR, Somayaji R, Dumanski SM, Ganshorn H, Greene DN, Collister D, Newbert AM, Peace L, Ahmed SB.
    Am J Physiol Heart Circ Physiol; 2024 Aug 01; 327(2):H340-H348. PubMed ID: 38578239
    [Abstract] [Full Text] [Related]

  • 15. Bone Mineral Density in Transgender Individuals After Gonadectomy and Long-Term Gender-Affirming Hormonal Treatment.
    Dobrolińska M, van der Tuuk K, Vink P, van den Berg M, Schuringa A, Monroy-Gonzalez AG, García DV, Schultz WCMW, Slart RHJA.
    J Sex Med; 2019 Sep 01; 16(9):1469-1477. PubMed ID: 31326306
    [Abstract] [Full Text] [Related]

  • 16. Assessment of Gender-Affirming Hormone Therapy Requirements.
    Fernandez JD, Kendjorsky K, Narla A, Villasante-Tezanos AG, Tannock LR.
    LGBT Health; 2019 Apr 01; 6(3):101-106. PubMed ID: 30810452
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.